Cytogenomic Investigation of Syndromic Brazilian Patients with Differences of Sexual Development

Background: Cytogenomic methods have gained space in the clinical investigation of patients with disorders/differences in sexual development (DSD). Here we evaluated the role of the SNP array in achieving a molecular diagnosis in Brazilian patients with syndromic DSD of unknown etiology. Methods: Tw...

Full description

Bibliographic Details
Main Authors: José Antonio Diniz Faria, Daniela R. Moraes, Leslie Domenici Kulikowski, Rafael Loch Batista, Nathalia Lisboa Gomes, Mirian Yumie Nishi, Evelin Zanardo, Carolina Kymie Vasques Nonaka, Bruno Solano de Freitas Souza, Berenice Bilharinho Mendonca, Sorahia Domenice
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/13/13/2235
_version_ 1797591920000630784
author José Antonio Diniz Faria
Daniela R. Moraes
Leslie Domenici Kulikowski
Rafael Loch Batista
Nathalia Lisboa Gomes
Mirian Yumie Nishi
Evelin Zanardo
Carolina Kymie Vasques Nonaka
Bruno Solano de Freitas Souza
Berenice Bilharinho Mendonca
Sorahia Domenice
author_facet José Antonio Diniz Faria
Daniela R. Moraes
Leslie Domenici Kulikowski
Rafael Loch Batista
Nathalia Lisboa Gomes
Mirian Yumie Nishi
Evelin Zanardo
Carolina Kymie Vasques Nonaka
Bruno Solano de Freitas Souza
Berenice Bilharinho Mendonca
Sorahia Domenice
author_sort José Antonio Diniz Faria
collection DOAJ
description Background: Cytogenomic methods have gained space in the clinical investigation of patients with disorders/differences in sexual development (DSD). Here we evaluated the role of the SNP array in achieving a molecular diagnosis in Brazilian patients with syndromic DSD of unknown etiology. Methods: Twenty-two patients with DSD and syndromic features were included in the study and underwent SNP-array analysis. Results: In two patients, the diagnosis of 46,XX <i>SRY +</i> DSD was established. Additionally, two deletions were revealed (3q29 and Xp22.33), justifying the syndromic phenotype in these patients. Two pathogenic CNVs, a 10q25.3-q26.2 and a 13q33.1 deletion encompassing the <i>FGFR2</i> and the <i>EFNB2</i> gene, were associated with genital atypia and syndromic characteristics in two patients with 46,XY DSD. In a third 46,XY DSD patient, we identified a duplication in the 14q11.2-q12 region of 6.5 Mb associated with a deletion in the 21p11.2-q21.3 region of 12.7 Mb. In a 46,XY DSD patient with delayed neuropsychomotor development and congenital cataracts, a 12 Kb deletion on chromosome 10 was found, partially clarifying the syndromic phenotype, but not the genital atypia. Conclusions: The SNP array is a useful tool for DSD patients, identifying the molecular etiology in 40% (2/5) of patients with 46,XX DSD and 17.6% (3/17) of patients with 46,XY DSD.
first_indexed 2024-03-11T01:44:24Z
format Article
id doaj.art-b32db0017fb14b7bab0f56bf25c89704
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-11T01:44:24Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-b32db0017fb14b7bab0f56bf25c897042023-11-18T16:21:55ZengMDPI AGDiagnostics2075-44182023-06-011313223510.3390/diagnostics13132235Cytogenomic Investigation of Syndromic Brazilian Patients with Differences of Sexual DevelopmentJosé Antonio Diniz Faria0Daniela R. Moraes1Leslie Domenici Kulikowski2Rafael Loch Batista3Nathalia Lisboa Gomes4Mirian Yumie Nishi5Evelin Zanardo6Carolina Kymie Vasques Nonaka7Bruno Solano de Freitas Souza8Berenice Bilharinho Mendonca9Sorahia Domenice10Faculdade de Medicina, Universidade Federal da Bahia, Salvador 40110-909, BrazilUnidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular LIM/42, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo 05403-010, BrazilLaboratório de Citogenômica e Patologia Molecular LIM/03, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo 05403-010, BrazilUnidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular LIM/42, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo 05403-010, BrazilUnidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular LIM/42, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo 05403-010, BrazilUnidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular LIM/42, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo 05403-010, BrazilLaboratório de Citogenômica e Patologia Molecular LIM/03, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo 05403-010, BrazilCentro de Biotecnologia e Terapia Celular, Hospital São Rafael, Salvador 41253-190, BrazilCentro de Biotecnologia e Terapia Celular, Hospital São Rafael, Salvador 41253-190, BrazilUnidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular LIM/42, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo 05403-010, BrazilUnidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular LIM/42, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo 05403-010, BrazilBackground: Cytogenomic methods have gained space in the clinical investigation of patients with disorders/differences in sexual development (DSD). Here we evaluated the role of the SNP array in achieving a molecular diagnosis in Brazilian patients with syndromic DSD of unknown etiology. Methods: Twenty-two patients with DSD and syndromic features were included in the study and underwent SNP-array analysis. Results: In two patients, the diagnosis of 46,XX <i>SRY +</i> DSD was established. Additionally, two deletions were revealed (3q29 and Xp22.33), justifying the syndromic phenotype in these patients. Two pathogenic CNVs, a 10q25.3-q26.2 and a 13q33.1 deletion encompassing the <i>FGFR2</i> and the <i>EFNB2</i> gene, were associated with genital atypia and syndromic characteristics in two patients with 46,XY DSD. In a third 46,XY DSD patient, we identified a duplication in the 14q11.2-q12 region of 6.5 Mb associated with a deletion in the 21p11.2-q21.3 region of 12.7 Mb. In a 46,XY DSD patient with delayed neuropsychomotor development and congenital cataracts, a 12 Kb deletion on chromosome 10 was found, partially clarifying the syndromic phenotype, but not the genital atypia. Conclusions: The SNP array is a useful tool for DSD patients, identifying the molecular etiology in 40% (2/5) of patients with 46,XX DSD and 17.6% (3/17) of patients with 46,XY DSD.https://www.mdpi.com/2075-4418/13/13/2235disorders of sexual developmentcopy number variationSNP array
spellingShingle José Antonio Diniz Faria
Daniela R. Moraes
Leslie Domenici Kulikowski
Rafael Loch Batista
Nathalia Lisboa Gomes
Mirian Yumie Nishi
Evelin Zanardo
Carolina Kymie Vasques Nonaka
Bruno Solano de Freitas Souza
Berenice Bilharinho Mendonca
Sorahia Domenice
Cytogenomic Investigation of Syndromic Brazilian Patients with Differences of Sexual Development
Diagnostics
disorders of sexual development
copy number variation
SNP array
title Cytogenomic Investigation of Syndromic Brazilian Patients with Differences of Sexual Development
title_full Cytogenomic Investigation of Syndromic Brazilian Patients with Differences of Sexual Development
title_fullStr Cytogenomic Investigation of Syndromic Brazilian Patients with Differences of Sexual Development
title_full_unstemmed Cytogenomic Investigation of Syndromic Brazilian Patients with Differences of Sexual Development
title_short Cytogenomic Investigation of Syndromic Brazilian Patients with Differences of Sexual Development
title_sort cytogenomic investigation of syndromic brazilian patients with differences of sexual development
topic disorders of sexual development
copy number variation
SNP array
url https://www.mdpi.com/2075-4418/13/13/2235
work_keys_str_mv AT joseantoniodinizfaria cytogenomicinvestigationofsyndromicbrazilianpatientswithdifferencesofsexualdevelopment
AT danielarmoraes cytogenomicinvestigationofsyndromicbrazilianpatientswithdifferencesofsexualdevelopment
AT lesliedomenicikulikowski cytogenomicinvestigationofsyndromicbrazilianpatientswithdifferencesofsexualdevelopment
AT rafaellochbatista cytogenomicinvestigationofsyndromicbrazilianpatientswithdifferencesofsexualdevelopment
AT nathalialisboagomes cytogenomicinvestigationofsyndromicbrazilianpatientswithdifferencesofsexualdevelopment
AT mirianyumienishi cytogenomicinvestigationofsyndromicbrazilianpatientswithdifferencesofsexualdevelopment
AT evelinzanardo cytogenomicinvestigationofsyndromicbrazilianpatientswithdifferencesofsexualdevelopment
AT carolinakymievasquesnonaka cytogenomicinvestigationofsyndromicbrazilianpatientswithdifferencesofsexualdevelopment
AT brunosolanodefreitassouza cytogenomicinvestigationofsyndromicbrazilianpatientswithdifferencesofsexualdevelopment
AT berenicebilharinhomendonca cytogenomicinvestigationofsyndromicbrazilianpatientswithdifferencesofsexualdevelopment
AT sorahiadomenice cytogenomicinvestigationofsyndromicbrazilianpatientswithdifferencesofsexualdevelopment